Evidence map›Paper›PMID 24849857›Full record

ArticleThe Lancet. Neurology2014

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply.

Steven M Greenberg, Rustam Al-Shahi Salman, Geert Jan Biessels, Mark van Buchem, Charlotte Cordonnier, Jin-Moo Lee, Joan Montaner, Julie A Schneider, Eric E Smith, Meike Vernooij and 1 more

Abstract readLetterComment
In one paragraph

Article in The Lancet. Neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Steven M GreenbergMGH Stroke Research Center, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: sgreenberg@mgh.harvard.edu.
Rustam Al-Shahi SalmanDivision of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Geert Jan BiesselsBrain Centre Rudolf Magnus, University Medical Center of Utrecht, Utrecht, Netherlands.
Mark van BuchemDepartment of Radiology, Leiden University Medical Center, Leiden, Netherlands.
Charlotte CordonnierDepartment of Neurology, Universite Lille Nord de France, Lille University Hospital, Lille, France.
Jin-Moo LeeDepartment of Neurology, Department of Radiology, and Department of Biomedical Engineering, Washington University School of Medicine, St Louis, MO, USA.
Joan MontanerDepartment of Neurology, Vall d'Hebron University Hospital and Research Institute, Autonomus University of Barcelona, Barcelona, Spain.
Julie A SchneiderDepartment of Pathology and Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Eric E SmithHotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Meike VernooijDepartment of Radiology and Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands.
David J WerringUCL Institute of Neurology, London, UK.

Funding

Vascular Dysfunction in Cerebral Amyloid AngiopathyR01AG026484 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GREENBERG, STEVEN M · 2005 to 2019
$7.5M
AMYLOID INDUCED CEREBROENDOTHELIAL DEGENERATIONR01NS040525 · NINDS · WASHINGTON UNIVERSITY · PI LEE, JIN-MOO · 2000 to 2004
$1.9M
Mechanisms of Amyloid Angiopathy-Related HemorrhageR01NS048283 · NINDS · WASHINGTON UNIVERSITY · PI LEE, JIN-MOO · 2005 to 2009
$1.5M
Untangling Amyloid Plaques With ProteasesR01NS067905 · NINDS · WASHINGTON UNIVERSITY · PI LEE, JIN-MOO · 2009 to 2010
$850k
Medical Research Council G1002605NIA NIH HHS R01 AG026484NINDS NIH HHS R01 NS040525NINDS NIH HHS R01 NS048283NINDS NIH HHS R01 NS067905
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersCerebral Amyloid AngiopathyHumansBiomarkers

Identifiers

PMID24849857
PMCPMC9242618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.